Yan Hu's most recent trade in Atara Biotherapeutics Inc was a trade of 1,668 Common Stock done at an average price of $11.6 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.61 per share. | 18 Aug 2025 | 1,668 | 35,258 (0%) | 0% | 11.6 | 19,372 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 18 Aug 2025 | 86 | 36,926 (0%) | 0% | 11.6 | 999 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 11.60 per share. | 18 Aug 2025 | 55 | 37,012 (0%) | 0% | 11.6 | 638 | Common Stock |
| Atara Biotherapeutics Inc | Yanina Grant-Huerta | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 16 May 2025 | 2,218 | 37,067 (0%) | 0% | 6.8 | 15,000 | Common Stock |
| Korea Fund Inc | Yan Hu | Director | Purchase of securities on an exchange or from another person at price $ 20.72 per share. | 26 Sep 2023 | 500 | 500 | - | 20.7 | 10,360 | Ordinary Shares |